Paper35110951
Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030.
Sintusek P and 3 others. World J Gastroenterol, 2022. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030. Papers, record 35110951. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35110951
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatitis B | Major topic |
| Hepatitis C | Major topic |
| Hepatitis, Viral, Human | Major topic |
| Liver Transplantation | Major topic |
| Child | |
| Goals | |
| Humans |
Source PubMed
References150
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31004661 | Screening of novel drugs for inhibiting hepatitis E virus replication. | J Virol Methods | 2019 | https://conductscience.org/library/papers/31004661 | PubMed |
| 2 | 10364031 | Immunogenicity of hepatitis A vaccine in decompensated liver disease. | Am J Gastroenterol | 1999 | https://conductscience.org/library/papers/10364031 | PubMed |
| 3 | 17226912 | Immunogenicity of recombinant hepatitis B virus vaccine in patients with and without chronic hepatitis C virus infection: a case-control study. | World J Gastroenterol | 2007 | https://conductscience.org/library/papers/17226912 | PubMed |
| 4 | 11359972 | Sero-epidemiology of hepatitis E virus (HEV) in urban and rural children of North India. | Indian Pediatr | 2001 | https://conductscience.org/library/papers/11359972 | PubMed |
| 5 | 28634131 | Cost Effectiveness of Pre- vs Post-Liver Transplant Hepatitis C Treatment With Direct-Acting Antivirals. | Clin Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/28634131 | PubMed |
| 6 | 12437618 | Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors. | Clin Transplant | 2002 | https://conductscience.org/library/papers/12437618 | PubMed |
| 7 | 34359335 | Hepatitis C Diagnosis: Simplified Solutions, Predictive Barriers, and Future Promises. | Diagnostics (Basel) | 2021 | https://conductscience.org/library/papers/34359335 | PubMed |
| 8 | 31905358 | Evolution and Revolution of Hepatitis C Management: From Non-A, Non-B Hepatitis Toward Global Elimination. | Dig Dis | 2020 | https://conductscience.org/library/papers/31905358 | PubMed |
| 9 | 34575286 | Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years-Results of the POLAC Project. | J Clin Med | 2021 | https://conductscience.org/library/papers/34575286 | PubMed |
| 10 | 22841195 | Response to vaccination against hepatitis B virus with a schedule of four 40-μg doses in cirrhotic patients evaluated for liver transplantation: factors associated with a response. | Transplant Proc | 2012 | https://conductscience.org/library/papers/22841195 | PubMed |
| 11 | 19030730 | Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list. | Braz J Infect Dis | 2008 | https://conductscience.org/library/papers/19030730 | PubMed |
| 12 | 26199756 | Prevalence of Hepatitis E Virus among Adults in South-West of Iran. | Hepat Res Treat | 2015 | https://conductscience.org/library/papers/26199756 | PubMed |
| 13 | 25789969 | T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. | Cell Death Dis | 2015 | https://conductscience.org/library/papers/25789969 | PubMed |
| 14 | 33567193 | Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33567193 | PubMed |
| 15 | 33090882 | Pharmacotherapy options for managing hepatitis B in children. | Expert Opin Pharmacother | 2021 | https://conductscience.org/library/papers/33090882 | PubMed |
| 16 | 18651907 | A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. | Transfusion | 2008 | https://conductscience.org/library/papers/18651907 | PubMed |
| 17 | 25495572 | Outcomes in pediatric hepatitis C transplant recipients: analysis of the UNOS database. | Pediatr Transplant | 2015 | https://conductscience.org/library/papers/25495572 | PubMed |
| 18 | 9703524 | Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. | BMJ | 1998 | https://conductscience.org/library/papers/9703524 | PubMed |
| 19 | 29154369 | Hepatitis E virus infection. | Nat Rev Dis Primers | 2017 | https://conductscience.org/library/papers/29154369 | PubMed |
| 20 | 26922272 | Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis. | Lancet Infect Dis | 2016 | https://conductscience.org/library/papers/26922272 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 36950163 | Hepatitis B virus infection among the tribal and particularly vulnerable tribal population from an eastern state of India: Findings from the serosurvey in seven tribal dominated districts, 2021-2022. | Front Microbiol | 2023 | https://conductscience.org/library/papers/36950163 |
Source PubMed
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA2 | 3440 | PubTator's text mining | https://conductscience.org/library/genes/3440 | NCBI Gene |
| IFNL3 | 282617 | PubTator's text mining | https://conductscience.org/library/genes/282617 | NCBI Gene |
| KRT88P | 85348 | PubTator's text mining | https://conductscience.org/library/genes/85348 | NCBI Gene |
| TLR8 | 51311 | PubTator's text mining | https://conductscience.org/library/genes/51311 | NCBI Gene |
| TLR9 | 54106 | PubTator's text mining | https://conductscience.org/library/genes/54106 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35110951
GET https://conductscience.org/api/papers/v1/35110951/references?page=2